Size-dependent activation of CAR-T cells

Area of Science:

• Immunology
• Molecular Biology
• Cancer Therapy

Background:

• Chimeric antigen receptor (CAR)-T cell therapy is expanding to new diseases, necessitating better antigen targeting and CAR design.
• Current CAR design is limited by incomplete understanding of antigen-mediated CAR activation mechanisms.

Purpose of the Study:

• To elucidate the molecular mechanism of CAR activation by antigens.
• To propose and validate a "size exclusion" model for CAR activation.

Main Methods:

• Investigated CAR activation using in vitro assays and a mouse lymphoma model.
• Manipulated the size of CAR extracellular domains and CD45 (a phosphatase).
• Compared CAR-T cell activation with different CAR isoforms and epitope binding sites.

Main Results:

• A "size exclusion" model was supported, where antigen engagement excludes CD45, promoting CAR phosphorylation and T cell activation.
• Larger CAR extracellular domains reduced CAR-T activation.
• Membrane-proximal epitopes were more effective than membrane-distal epitopes.
• Increasing CD45 size enhanced CAR activation for membrane-distal epitopes.
• Larger CD45 isoforms (CD45RABC) led to higher CAR-T activation than smaller isoforms (CD45RO).

Conclusions:

• CAR-T cell activation is critically dependent on the size difference between the CAR-antigen complex and CD45.
• CAR, antigen, and CD45 size are tunable parameters for optimizing CAR-T cell therapy efficacy.